Charles Schwab Investment Management Inc Corcept Therapeutics Inc Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,026,487 shares of CORT stock, worth $68.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,026,487
Previous 973,296 5.47%
Holding current value
$68.7 Million
Previous $31.6 Million 50.16%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$29.51 - $46.26 $1.57 Million - $2.46 Million
53,191 Added 5.47%
1,026,487 $47.5 Million
Q2 2024

Aug 12, 2024
BUY
$22.21 - $34.48 $884,735 - $1.37 Million
39,835 Added 4.27%
973,296 $31.6 Million
Q1 2024

May 08, 2024
BUY
$21.1 - $27.46 $696,658 - $906,646
33,017 Added 3.67%
933,461 $23.5 Million
Q4 2023

Feb 06, 2024
BUY
$24.82 - $32.88 $970,735 - $1.29 Million
39,111 Added 4.54%
900,444 $29.2 Million
Q3 2023

Nov 08, 2023
BUY
$21.97 - $33.8 $387,462 - $596,096
17,636 Added 2.09%
861,333 $23.5 Million
Q2 2023

Aug 09, 2023
SELL
$21.44 - $25.15 $991,943 - $1.16 Million
-46,266 Reduced 5.2%
843,697 $18.8 Million
Q1 2023

May 11, 2023
SELL
$19.2 - $24.47 $2,169 - $2,765
-113 Reduced 0.01%
889,963 $19.3 Million
Q4 2022

Feb 13, 2023
BUY
$19.95 - $29.96 $1.35 Million - $2.02 Million
67,419 Added 8.2%
890,076 $18.1 Million
Q3 2022

Nov 14, 2022
BUY
$24.7 - $29.12 $184,385 - $217,380
7,465 Added 0.92%
822,657 $21.1 Million
Q2 2022

Aug 15, 2022
BUY
$17.33 - $25.3 $510,819 - $745,742
29,476 Added 3.75%
815,192 $19.4 Million
Q1 2022

May 13, 2022
BUY
$16.53 - $25.21 $1.75 Million - $2.67 Million
105,951 Added 15.59%
785,716 $17.7 Million
Q4 2021

Feb 11, 2022
SELL
$17.1 - $23.34 $1.46 Million - $2 Million
-85,672 Reduced 11.19%
679,765 $13.5 Million
Q3 2021

Nov 16, 2021
SELL
$19.68 - $22.53 $2,066 - $2,365
-105 Reduced 0.01%
765,437 $15.1 Million
Q2 2021

Aug 16, 2021
SELL
$19.97 - $24.43 $496,593 - $607,500
-24,867 Reduced 3.15%
765,542 $16.8 Million
Q1 2021

May 17, 2021
BUY
$23.49 - $30.56 $621,404 - $808,434
26,454 Added 3.46%
790,409 $18.8 Million
Q4 2020

Feb 16, 2021
BUY
$16.78 - $27.3 $237,822 - $386,922
14,173 Added 1.89%
763,955 $20 Million
Q3 2020

Nov 13, 2020
SELL
$12.46 - $19.98 $200,306 - $321,198
-16,076 Reduced 2.1%
749,782 $13.1 Million
Q2 2020

Aug 14, 2020
BUY
$11.0 - $18.26 $819,258 - $1.36 Million
74,478 Added 10.77%
765,858 $12.9 Million
Q1 2020

May 15, 2020
BUY
$10.11 - $14.04 $44,564 - $61,888
4,408 Added 0.64%
691,380 $8.22 Million
Q4 2019

Feb 07, 2020
BUY
$12.06 - $16.96 $1.04 Million - $1.47 Million
86,617 Added 14.43%
686,972 $8.31 Million
Q3 2019

Nov 08, 2019
BUY
$10.41 - $14.66 $83,862 - $118,100
8,056 Added 1.36%
600,355 $8.49 Million
Q2 2019

Aug 09, 2019
BUY
$9.78 - $12.76 $105,428 - $137,552
10,780 Added 1.85%
592,299 $6.61 Million
Q1 2019

May 14, 2019
BUY
$10.03 - $15.71 $193,077 - $302,417
19,250 Added 3.42%
581,519 $6.83 Million
Q4 2018

Feb 14, 2019
BUY
$11.29 - $17.19 $632 - $962
56 Added 0.01%
562,269 $7.51 Million
Q3 2018

Nov 13, 2018
BUY
$12.27 - $15.65 $739,586 - $943,319
60,276 Added 12.01%
562,213 $7.88 Million
Q2 2018

Aug 08, 2018
BUY
$15.3 - $19.69 $172,492 - $221,985
11,274 Added 2.3%
501,937 $7.89 Million
Q1 2018

May 07, 2018
BUY
$14.59 - $25.5 $142,092 - $248,344
9,739 Added 2.03%
490,663 $8.07 Million
Q4 2017

Jan 17, 2018
BUY
$15.77 - $20.72 $1.05 Million - $1.38 Million
66,749 Added 16.12%
480,924 $8.69 Million
Q3 2017

Nov 13, 2017
BUY
$12.3 - $19.3 $5.09 Million - $7.99 Million
414,175
414,175 $7.99 Million

Others Institutions Holding CORT

# of Institutions
355
Shares Held
86.2M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.17B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email